⌘K

Login Start Free

Home/Filings/4/0001235802-19-000062

4//SEC Filing

Kellen Scott 4

Accession 0001235802-19-000062

CIK 0001401040other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:30 PM ET

Size

5.9 KB

Accession

0001235802-19-000062

Insider Transaction Report

Form 4

Period: 2019-06-24

DiaMedica Therapeutics Inc.DMAC

CFO & Secretary

Transactions

Award
Stock Option (right to buy)
2019-06-24+99,750→ 99,750 total
Exercise: $4.60Exp: 2029-06-23→ Common Shares (99,750 underlying)

Holdings

Voting Common Shares, no par value per share
7,290

Footnotes (1)

[F1]Vests in eight nearly equal quarterly installments over two years.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1

filerCIK 0001490476

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 4:30 PM ET
Size: 5.9 KB

View on SEC.gov